Electrocore Inc (ECOR) Stock Price, Quote & News

Company Profile

electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also deve...

Industry: Medical Devices

Sector: Healthcare

Phone: 973 290 0097

Fax: 973 290 9171

Website: www.electrocore.com

Address:

200 Forge Way, Suite 205, Rockaway, United States

taxplanr Nov. 13 at 8:54 PM

$ECOR picked up a hedge fund https://investor.electrocore.com/node/11881/html

1 · Reply

Trekingirl Nov. 12 at 11:36 AM

$ECOR nice slow steady climb

0 · Reply

DARKP00L Nov. 11 at 9:23 PM

$ECOR 15:53 on Nov. 11 2025 ElectroCore Granted Patent # US 12469610 B2 For "SYSTEMS AND METHODS FOR TREATING BLOOD CLOTS WITH NERVE STIMULATION" #tradeideas

0 · Reply

taxplanr Nov. 11 at 3:40 PM

Combining no side effects PEMF $ECOR with Ivermectin Fenbendazole and Menbendazole will bring end to abuse of cancer patients from $BNTX $MRNA $PFE https://www.fagronacademy.us/blog/antiparasitic-agents-and-emerging-data-on-their-utility-as-a-cancer-treatment

1 · Reply

taxplanr Nov. 11 at 3:19 PM

$ECOR PEMF causes apoptosis of cancer cells while making surrounding cells heal faster NsPEFs with 900 ns Pulse Duration Induced Late Apoptosis/Necrosis of TPC-1 Cells NsPEFs with 900 ns Pulse Duration Inhibited the Proliferation of TPC-1 Cells NsPEFs with 900 ns Pulse Duration Induced Apoptosis in TPC-1 Cells it preserves the integrity of the supporting tissue [27]. In the end, tissue after nsPEFs ablation repaired and healed more quickly. Compared to malignantRNA damaging all cells $BNTX $PFE $MRNA $MRK https://onlinelibrary.wiley.com/doi/full/10.1155/2021/9913716

0 · Reply

StockScanners Nov. 8 at 5:11 AM

$ECOR reached 6.24

0 · Reply

Mudloaf Nov. 8 at 2:20 AM

$ECOR still some sellers who want out, but the trajectory now should be up. A lot

0 · Reply

ForeignInfluence Nov. 7 at 8:25 PM

$ECOR Average Target Price $21.08. Number Of Ratings 5. FY Report Date 12/2025.

0 · Reply

ForeignInfluence Nov. 7 at 8:23 PM

$ECOR 1st Resistance Point $6.31 at this level.

0 · Reply

ForeignInfluence Nov. 7 at 8:22 PM

$ECOR Nice.

0 · Reply

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Nov 5, 2025, 9:51 PM EST - 8 days ago

electroCore, Inc. (ECOR) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:05 PM EST - 9 days ago

electroCore Announces Third Quarter 2025 Financial Results

Oct 23, 2025, 8:11 AM EDT - 22 days ago

electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025

Oct 3, 2025, 4:05 PM EDT - 6 weeks ago

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Sep 30, 2025, 8:00 AM EDT - 6 weeks ago

gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms

Sep 29, 2025, 8:00 AM EDT - 6 weeks ago

electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium

Sep 22, 2025, 8:00 AM EDT - 7 weeks ago

electroCore's Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire's 2025 Sleep Awards

Sep 9, 2025, 2:21 PM EDT - 2 months ago

Ecora Resources PLC (ECOR:CA) Q2 2025 Earnings Call Transcript

Sep 5, 2025, 8:00 AM EDT - 2 months ago

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board

Sep 4, 2025, 8:00 AM EDT - 2 months ago

electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief

Sep 3, 2025, 8:00 AM EDT - 2 months ago

electroCore Appoints Elena Bonfiglioli to Board of Directors

Sep 2, 2025, 8:00 AM EDT - 2 months ago

electroCore to Participate at H.C. Wainwright Global Investment Conference

Aug 12, 2025, 8:00 AM EDT - 3 months ago

electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga

Aug 6, 2025, 11:18 PM EDT - 3 months ago

electroCore, Inc. (ECOR) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:05 PM EDT - 3 months ago

electroCore Announces Second Quarter 2025 Financial Results

Aug 5, 2025, 8:00 AM EDT - 3 months ago

electroCore Appoints James C. Theofilos to the Board of Directors

Jul 23, 2025, 8:00 AM EDT - 4 months ago

electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025

Jul 22, 2025, 4:05 PM EDT - 4 months ago

electroCore to Participate in Upcoming Investor Conferences

May 7, 2025, 11:16 PM EDT - 6 months ago

electroCore, Inc. (ECOR) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 6 months ago

electroCore Announces First Quarter 2025 Financial Results

May 2, 2025, 8:00 AM EDT - 7 months ago

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies

May 1, 2025, 8:00 AM EDT - 7 months ago

electroCore's Truvaga™ Now Works with the Apple Health app

Apr 30, 2025, 8:00 AM EDT - 7 months ago

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

Apr 17, 2025, 8:00 AM EDT - 7 months ago

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

Apr 16, 2025, 8:00 AM EDT - 7 months ago

electroCore to Participate at the Planet MicroCap Showcase

Apr 3, 2025, 8:00 AM EDT - 8 months ago

electroCore Named One of The Americas' Fastest Growing Companies by the Financial Times

Apr 1, 2025, 8:00 AM EDT - 8 months ago

electroCore to Participate at the Needham Virtual Healthcare Conference

Mar 31, 2025, 8:00 AM EDT - 8 months ago

electroCore Extends VA Contract for Five Years

Mar 12, 2025, 9:36 PM EDT - 8 months ago

electroCore, Inc. (ECOR) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 4:05 PM EDT - 8 months ago

electroCore Announces Full Year 2024 Financial Results

Mar 6, 2025, 8:00 AM EST - 9 months ago

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025

Mar 5, 2025, 8:00 AM EST - 9 months ago

electroCore to Participate at Upcoming Investor Conferences

Feb 27, 2025, 8:00 AM EST - 9 months ago

electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal

Feb 4, 2025, 8:00 AM EST - 10 months ago

electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 14, 2025, 10:17 AM EST - 10 months ago

electroCore: An Opportunity In Medical And Wellness Device Innovation

Dec 30, 2024, 1:59 PM EST - 11 months ago

electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM

Dec 17, 2024, 4:05 PM EST - 11 months ago

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

Nov 14, 2024, 8:00 AM EST - 1 year ago

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

Nov 13, 2024, 9:18 PM EST - 1 year ago

electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 1 year ago

electroCore Announces Third Quarter 2024 Financial Results

Nov 12, 2024, 4:01 PM EST - 1 year ago

ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award

Oct 14, 2024, 8:00 AM EDT - 1 year ago

electroCore to Participate at LD Micro Main Event VXII

Sep 10, 2024, 8:00 AM EDT - 1 year ago

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

Sep 4, 2024, 8:00 AM EDT - 1 year ago

electroCore to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 10, 2024, 4:27 AM EDT - 1 year ago

electroCore, Inc. (ECOR) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:01 PM EDT - 1 year ago

electroCore Announces Second Quarter 2024 Financial Results

Jun 25, 2024, 8:00 AM EDT - 1 year ago

electroCore Announces the Commercial Launch of TAC-STIM™

Jun 3, 2024, 8:30 AM EDT - 1 year ago

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

May 8, 2024, 10:19 PM EDT - 1 year ago

electroCore, Inc. (ECOR) Q1 2024 Earnings Call Transcript

taxplanr Nov. 13 at 8:54 PM

$ECOR picked up a hedge fund https://investor.electrocore.com/node/11881/html

1 · Reply

Trekingirl Nov. 12 at 11:36 AM

$ECOR nice slow steady climb

0 · Reply

DARKP00L Nov. 11 at 9:23 PM

$ECOR 15:53 on Nov. 11 2025 ElectroCore Granted Patent # US 12469610 B2 For "SYSTEMS AND METHODS FOR TREATING BLOOD CLOTS WITH NERVE STIMULATION" #tradeideas

0 · Reply

taxplanr Nov. 11 at 3:40 PM

1 · Reply

taxplanr Nov. 11 at 3:19 PM

0 · Reply

StockScanners Nov. 8 at 5:11 AM

$ECOR reached 6.24

0 · Reply

Mudloaf Nov. 8 at 2:20 AM

$ECOR still some sellers who want out, but the trajectory now should be up. A lot

0 · Reply

ForeignInfluence Nov. 7 at 8:25 PM

$ECOR Average Target Price $21.08. Number Of Ratings 5. FY Report Date 12/2025.

0 · Reply

ForeignInfluence Nov. 7 at 8:23 PM

$ECOR 1st Resistance Point $6.31 at this level.

0 · Reply

ForeignInfluence Nov. 7 at 8:22 PM

$ECOR Nice.

0 · Reply

PLATINUM_TRADES Nov. 7 at 5:11 PM

$ECOR $6.26 High before the dump.... Nice profits

0 · Reply

taxplanr Nov. 7 at 2:51 PM

$ECOR i don't mind our Chinese whale and industrialist pushing the capabilities envelope and paying for PEMF research with Truvaga that can be used here also how about you?

0 · Reply

PLATINUM_TRADES Nov. 7 at 2:36 PM

$ECOR Break $6.00 looks awesome 🚨🚨

0 · Reply

Trekingirl Nov. 7 at 8:11 AM

$ECOR Hold this one. No matter how high this stock has gone, the last time an insider sold was over 4 years ago. I have as do they, a lot of faith in this company.

0 · Reply

Trekingirl Nov. 7 at 7:46 AM

$ECOR I've been waiting for this to rip. Float is only 8 million.

0 · Reply

PaulLaurent Nov. 7 at 6:29 AM

📢📊 Unusual Volume Stocks 📊📢 $RAYC $ECOR $XBIT $AMOD $INVE

0 · Reply

StockScanners Nov. 7 at 1:51 AM

$ECOR keep watch if this holds above 5.60

0 · Reply

Arcides Nov. 7 at 1:26 AM

$ECOR stopped the bleeding...posible accumulation phase...

0 · Reply

ForeignInfluence Nov. 6 at 11:44 PM

$ECOR What gives?

0 · Reply

cgcapitalresearch Nov. 6 at 10:30 PM

$ECOR Bioelectric Company Posts Record Revenue, Raised Guidance, and Strength in Both VA and Wellness Channels - electroCore (ECOR) posted another record quarter in Q3 2025, reaffirming its position as a leader in non-invasive vagus nerve stimulation (nVNS) and consumer neuromodulation. - READ MORE: https://hubs.ly/Q03S6hPt0

0 · Reply

healthcareguru Nov. 5 at 10:38 PM

$ECOR STRONG 3Q print…10% topline beat and raising the guide by more than the beat => clear momentum/acceleration in growth and upside to 4Q estimates. Better cash mgmt too with inflection to FCF+ in sight. 🔥🔥🔥

3 · Reply

taxplanr Nov. 5 at 10:07 PM

$ECOR wrapping the Truvaga app with Quell is a great marketing coup

0 · Reply

Market Cap	48.46M
Revenue (ttm)	25.18M
Net Income (ttm)	-11.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-47.22%
Debt to Equity Ratio	-6.10

Volume	38,400
Avg Vol	59,478
Day's Range	N/A - N/A
Shares Out	8.00M
Stochastic %K	58%
Beta	0.30
Analysts	Strong Sell
Price Target	$21.35